One platform across the stroke pathway — hemorrhage, infarction, aneurysm, perfusion and 3D vascular imaging, on CT and MR. One solution is FDA-cleared today; seven more are in the FDA process. Select any solution for its description, capabilities, and performance evidence.
Detects and delineates suspected acute ischemic lesions on true acquired MR diffusion-weighted imaging, classifying each finding as vascular-territory or non-vascular-territory.
DWI (left) · AI infarct overlay (right)




Internal validation on an independent test set of 1,059 DWI studies (study-level analysis). Figures reflect internal analysis and are not a head-to-head comparison.
Sensitivity 0.97 · Specificity 0.96 · Processing under 80 seconds from series to result, on an independent test set.
⚠ Latest internal validation results